Journal
JOURNAL OF IMMUNOLOGY
Volume 199, Issue 2, Pages 391-396Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1601882
Keywords
-
Categories
Funding
- Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming
- Actions de Recherche Concertees of the Communaute Francaise de Belgique
- European Union's Horizon 2020 Research and Innovation Programme [682818]
- Fonds J. Maisin (Belgium)
- Fonds National pour la Recherche Scientifique (Belgium)
- European Research Council (ERC) [682818] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Production of active TGF-beta is regulated at a posttranslational level and implies release of the mature cytokine dimer from the inactive, latent TGF-beta precursor. There are several cell-type specific mechanisms of TGF-beta activation. We identified a new mechanism operating on the surface of human regulatory T cells and involving membrane protein GARP, which binds latent TGF-beta 1. The paracrine activity of regulatory T cell-derived TGF-beta 1 contributes to immunosuppression and can be inhibited with anti-GARP Abs. Whether other immune cell types use surface GARP to activate latent TGF-beta 1 was not known. We show in this study that stimulated, human B lymphocytes produce active TGF-beta 1 from surface GARP/latent TGF-beta 1 complexes with isotype switching to IgA production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available